Life science News and Research

RSS

World Fusion creates sequence analysis service center with bioinformatics infrastructure

Today Japanese informatics management experts, World Fusion, announced the creation of a sequence analysis service center with a bioinformatics infrastructure based on CLC bio's enterprise platform for high-throughtput sequencing data analysis, coupled with World Fusion's own Life Science Knowledge Bank (LSKB) bio knowledge database system.

19 Aug 2010

Exiqon reports 2010 second quarter revenue increases 27%

Exiqon today announced results for the first six months of 2010 ending 30 June 2010. Revenue for the first six months increased 27% to a record DKK 44.8 million.

19 Aug 2010

Fralin Life Science Institute professor receives grant from NSF to elucidate research on fungi

Pablo Sobrado, assistant professor of biochemistry with the Fralin Life Science Institute at Virginia Tech, has received a $1.1 million grant from the National Science Foundation (NSF) to advance his research on the mechanism of iron acquisition in fungi and mycobacteria.

19 Aug 2010

Regenicin acquires worldwide exclusive license to know-how technology

Regenicin, Inc., a development stage biotechnology company, announced today that it has completed an initial $3.25 million funding in conjunction with its acquisition of a worldwide exclusive license to know-how technology controlled by Lonza Walkersville ("Lonza Agreement").

18 Aug 2010

Life Technologies, CEVEC Pharmaceuticals sign licensing agreement to supply CAP-T expression kits

CEVEC Pharmaceuticals, the developer of a novel human protein expression system derived from amniocytes, announced today the signing of a co-exclusive worldwide licensing agreement with Life Technologies Corporation, a leading provider of innovative life science solutions based in Carlsbad, California. Under the terms of the agreement, Life Technologies and CEVEC will co-operate to offer optimized expression kits based on CEVEC's proprietary CAP-T cells to the global life science research community.

18 Aug 2010

Best practices for assessing toxicity during drug discovery process

Ingenuity® Systems, the leading provider of information solutions for life science researchers, today announced the release of the white paper, "Best Practices for Assessing Toxicity throughout the Drug Discovery Process: Toxicogenomics." The white paper is based on input from industry experts and shows how multidisciplinary toxicology teams in drug discovery can leverage toxicogenomics and IPA® for improved predictive toxicology and mechanistic toxicity analysis.

17 Aug 2010

Jackson Laboratory to implement HighRes automated process for genotyping of laboratory mice

A highly accurate, automated process for managing the genotyping of laboratory mice is headed to Bar Harbor, Maine. In response to the increased demand for using transgenic mouse models and the requisite genotyping of such animals, The Jackson Laboratory will be implementing a HighRes Biosolutions automated process to improve the maintenance of their extensive and diverse mouse colonies.

17 Aug 2010

Michigan Accelerator Fund 1 launched to support early stage life science and technology companies

Michigan Accelerator Fund I, L.P., today announced the formation of the community's first venture capital fund formed specifically to support early stage life science and technology companies: the Michigan Accelerator Fund 1 (MAF1).

16 Aug 2010

Indiana University installs new DeltaVision|OMX imaging system from Applied Precision

Applied Precision, along with Indiana University, are excited to announce the installation of a new DeltaVision|OMX imaging system in the Light Microscopy Imaging Center in Bloomington, Indiana.

16 Aug 2010

Bruker to acquire Veeco’s worldwide SPM and OIM instruments business for $229 million

Bruker Corporation today announces the signing of an agreement to acquire the Scanning Probe Microscopy (SPM) and Optical Industrial Metrology (OIM) instruments business from Veeco Instruments, Inc. for $229 million in cash. The transaction has been approved by the Boards of Directors of both companies and is expected to close during the fourth quarter of 2010, pending regulatory review and subject to customary closing conditions.

16 Aug 2010

CLC bio, PSSC Labs announce new turnkey solution for full-genome assembly and analysis

Today, CLC bio and PSSC Labs announced a new turnkey solution, CLC Genomics Factory, for assembly, read mapping, and subsequent downstream analysis of very large amounts of high-throughput DNA and RNA sequencing data. Built as a high-performance bioinformatics appliance, CLC Genomics Factory comes in three different sizes with varying numbers of compute nodes, capable of processing the data output from up to 10 Illumina HiSeq2000 or 7 Life Technologies SOLiD 4 systems.

13 Aug 2010

TLV, Emergent BioSolutions form joint venture to develop broad spectrum pandemic flu vaccine

Temasek Life Science Ventures Pte Ltd and Emergent BioSolutions Inc. today announced their agreement to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture, and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused by a broad range of circulating H5 influenza strains.

12 Aug 2010

Swift Biosciences completes $3 million Series A financing

Swift Biosciences Inc., a Michigan-based life sciences company, today announced the recent completion of a $3 million Series A financing led by the venture firm DFJ Mercury. DFJ Mercury was joined in the Series A by several Michigan-based individual investors who also helped launch the Company with seed funding in January 2010. Daniel Watkins of DFJ Mercury will join the company's Board of Directors.

12 Aug 2010

Derycz Scientific subsidiary secures exclusive article reprints and ePrints services contract for JAMA

Derycz Scientific, Inc., a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, today announced that its subsidiary, Reprints Desk, has secured an exclusive, multi-year contract to provide article reprints and ePrints services for the Journal of the American Medical Association, the nine specialty Archives Journals published by the American Medical Association, American Medical News, and Disaster Medicine and Public Health Preparedness.

11 Aug 2010

Dicerna announces closing of $25 million Series B round of financing

Dicerna Pharmaceuticals, Inc., a second generation RNA interference company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA molecules, today announced that it has closed a $25 million Series B round of financing. New investor Domain Associates led the round, with all existing investors participating - Oxford Bioscience Partners, Skyline Ventures and Abingworth.

11 Aug 2010

Medicago USA awarded $21M to develop vaccine facility in Research Triangle Park

Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.

11 Aug 2010

ASEBIO to host Biospain 2010

The Spanish Bioindustry Association (ASEBIO), in collaboration with the Navarre Society of Development (SODENA), and the government of Navarre, will host BioSpain 2010 the biennial international gathering of experts in the biotechnology sector, in Pamplona from September 29th to October 1st. BioSpain 2010 is honoured to welcome three lecturers of international prestige: Mr. Carlos Cordon-Cardo, Vice-Chair of Pathology & Professor, Columbia University; Mr. Larry Fritz, President & CEO, Covella Pharmaceuticals Inc. and Life Science Venture Partner, Westfield Capital Management Company LP; and Mr. Conny Bogentoft, CEO Karolinska Development AB.

8 Aug 2010

Response Genetics total revenue for second-quarter 2010 increases 197% to $5.6 million

Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced its consolidated financial results for the three and six months ended June 30, 2010.

7 Aug 2010

Marken announces opening of branch office in Tokyo, Japan

Marken, a leading logistics specialist supporting the life science industry, today announced the opening of their branch office in Tokyo, Japan. The expansion office will handle the growing demand for management and support of Marken's Japanese services.

7 Aug 2010

VWR International signs agreement to acquire scientific distribution businesses of EBOS Group

VWR International, LLC, a leading global laboratory supply and distribution company, announced today that it has signed an agreement to acquire the scientific distribution businesses of EBOS Group Limited, subject to customary closing conditions. The parties anticipate completion of the transaction on or about September 1, 2010.

6 Aug 2010

Life science News and Research

World Fusion creates sequence analysis service center with bioinformatics infrastructure

Exiqon reports 2010 second quarter revenue increases 27%

Fralin Life Science Institute professor receives grant from NSF to elucidate research on fungi

Regenicin acquires worldwide exclusive license to know-how technology

Life Technologies, CEVEC Pharmaceuticals sign licensing agreement to supply CAP-T expression kits

Best practices for assessing toxicity during drug discovery process

Jackson Laboratory to implement HighRes automated process for genotyping of laboratory mice

Michigan Accelerator Fund 1 launched to support early stage life science and technology companies

Indiana University installs new DeltaVision|OMX imaging system from Applied Precision

Bruker to acquire Veeco’s worldwide SPM and OIM instruments business for $229 million

CLC bio, PSSC Labs announce new turnkey solution for full-genome assembly and analysis

TLV, Emergent BioSolutions form joint venture to develop broad spectrum pandemic flu vaccine

Swift Biosciences completes $3 million Series A financing

Derycz Scientific subsidiary secures exclusive article reprints and ePrints services contract for JAMA

Dicerna announces closing of $25 million Series B round of financing

Medicago USA awarded $21M to develop vaccine facility in Research Triangle Park

ASEBIO to host Biospain 2010

Response Genetics total revenue for second-quarter 2010 increases 197% to $5.6 million

Marken announces opening of branch office in Tokyo, Japan

VWR International signs agreement to acquire scientific distribution businesses of EBOS Group

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News